Eyenovia Delays Q1 2025 10-Q Filing

Eyenovia ( (EYEN) ) has released a notification of late filing.

Eyenovia, Inc. has announced a delay in filing its Form 10-Q (Quarter Report) for the financial period ending March 31, 2025. The delay is primarily due to the ongoing evaluation of the second amendment to their Loan and Security Agreement with Avenue Capital Management. This process is nearing completion, and the company expects to file the report by May 20, 2025. Eyenovia anticipates a significant reduction in operating expenses for the quarter, attributed to a restructuring effort in late 2024. The company remains committed to compliance, as indicated by the signature of CEO Michael Rowe on the notification.

The most recent analyst rating on (EYEN) stock is a Buy with a $560.00 price target. To see the full list of analyst forecasts on Eyenovia stock, see the EYEN Stock Forecast page.

Spark’s Take on EYEN Stock

According to Spark, TipRanks’ AI Analyst, EYEN is a Underperform.

Eyenovia’s stock is heavily weighed down by poor financial performance, including significant operational losses and a weak balance sheet. While there is revenue growth, the negative equity and insufficient cash flow generation are critical risks. Technical indicators also point to a bearish trend, and the valuation metrics are unappealing due to a negative P/E ratio and absence of dividends. These factors result in a low overall score.

To see Spark’s full report on EYEN stock, click here.

More about Eyenovia

Average Trading Volume: 222,568

Technical Sentiment Signal: Sell

Current Market Cap: $3.26M

See more data about EYEN stock on TipRanks’ Stock Analysis page.